A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
Massachusetts General Hospital
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
Stanford University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Mayo Clinic
Thomas Jefferson University
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Advice Pharma Group srl
Mundipharma Research Limited
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Beth Israel Deaconess Medical Center
Washington University School of Medicine
University of Nebraska
University of Nebraska
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Northside Hospital, Inc.
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Virginia Commonwealth University
University of Virginia
Memorial Sloan Kettering Cancer Center
Scripps Health
Scripps Health
Columbia University
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Northwestern University
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
West Virginia University
Masonic Cancer Center, University of Minnesota
GPCR Therapeutics, Inc.
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
GPCR Therapeutics, Inc.